EV-301: A phase 3 study evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial cancer (la/mUC) who have progressed on platinum-containing chemotherapy or anti-PD-(L)1 therapy Meeting Abstract
| Authors: | Petrylak, D.; Rosenberg, J.; Duran, I.; Loriot, Y.; Sonpavde, G.; Wu, C.; Gartner, E.; Melhem-Bertrandt, A.; Powles, T. |
| Abstract Title: | EV-301: A phase 3 study evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial cancer (la/mUC) who have progressed on platinum-containing chemotherapy or anti-PD-(L)1 therapy |
| Meeting Title: | AACR Special Conference on Bladder Cancer: Transforming the Field |
| Journal Title: | Clinical Cancer Research |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 18-21 |
| Meeting Location: | Denver, CO |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Start Page: | 59 |
| End Page: | 60 |
| Language: | English |
| ACCESSION: | WOS:000558688000078 |
| PROVIDER: | wos |
| DOI: | 10.1158/1557-3265.BLADDER19-B26 |
| Notes: | Meeting Abstract: B26 -- Source: Wos |
